Video

What keeps you up at night in ophthalmology: Part VIII

Author(s):

David Hutton,Alex Delaney-Gesing

JD Schaub, chief operating officer at RVL Pharmaceuticals, shares what lingers on his mind in the ophthalmic field at the end of the day.


Watch the previous installments in this series:

What keeps you up at night in ophthalmology?

What keeps you up at night in ophthalmology: Part II

What keeps ophthalmologists up at night: Part III

What keeps ophthalmologists up at night: Part IV

What keeps you up at night in ophthalmology: Part V

What keeps you up at night in ophthalmology: Part VI

What keeps you up at night in ophthalmology: Part VII

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
Related Content
Winners of best poster presentation award at EnVision Summit 2025
March 6th 2025

Winners of best poster presentation award at EnVision Summit 2025

Envision Summit 2025: Advice on treating periorbital eye injuries
February 15th 2025

Envision Summit 2025: Advice on treating periorbital eye injuries

Envision Summit 2025: Importance of comanagement in glaucoma treatment
February 15th 2025

Envision Summit 2025: Importance of comanagement in glaucoma treatment

ARVO 2024: Detection of glaucoma with a novel widefield imaging device combined with OCT
May 16th 2024

ARVO 2024: Detection of glaucoma with a novel widefield imaging device combined with OCT

ARVO 2024: Abnormal subendothelial matrix exacerbates choroidal endothelial cell death in early AMD
May 16th 2024

ARVO 2024: Abnormal subendothelial matrix exacerbates choroidal endothelial cell death in early AMD

ARVO 2024: Exploratory analysis of pivotal phase 3 trials, YOSEMITE and RHINE, for vabysmo in DME
May 15th 2024

ARVO 2024: Exploratory analysis of pivotal phase 3 trials, YOSEMITE and RHINE, for vabysmo in DME

© 2025 MJH Life Sciences

All rights reserved.